Idiopathic Pulmonary Fibrosis Mortality by Industry and Occupation - United States, 2020-2022
- PMID: 40048397
- PMCID: PMC11956160
- DOI: 10.15585/mmwr.mm7407a1
Idiopathic Pulmonary Fibrosis Mortality by Industry and Occupation - United States, 2020-2022
Abstract
Idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring and worsening lung function, has a poor prognosis. A recent systematic review estimated that 21% of IPF deaths might be attributable to occupational exposures. To describe IPF mortality among U.S. residents aged ≥15 years who were ever employed, by industry and occupation, CDC conducted an exploratory analysis of 2020-2022 multiple cause-of-death data. During 2020-2022, a total of 67,843 (39,712 [59%] male and 28,131 [41%] female) decedents had IPF, suggesting that during this 3-year period, 8,340 IPF deaths in males and 5,908 deaths in females might have been associated with occupational exposures. By industry group, the highest proportionate mortality ratios among males were among those employed in utilities (1.15) and among females, were among those employed in public administration (1.12). By occupation group, the highest IPF mortality rates among males were among community and social services workers (1.23) and among females among farming, fishing, and forestry workers (1.24). Estimates of elevated IPF mortality among workers in specific industries and occupations warrant confirmation, control of known exposure-related risk factors, and continued surveillance to better understand the full range of occupational exposures that might increase risk for developing IPF.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
References
-
- Raghu G, Collard HR, Egan JJ, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824. 10.1164/rccm.2009-040GL - DOI - PMC - PubMed
-
- Pauchet A, Chaussavoine A, Pairon JC, et al. Idiopathic pulmonary fibrosis: what do we know about the role of occupational and environmental determinants? A systematic literature review and meta-analysis. J Toxicol Environ Health B Crit Rev 2022;25:372–92. 10.1080/10937404.2022.2131663 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical